BioSpace News Archive

SomaLogic, Inc., a leader in proteomics technology, announced that it is extending its collaborative agreement with global healthcare innovator, Novo Nordisk.

Eterna Therapeutics Inc. today announced the appointment of Dorothy Clarke to its Board of Directors.

TC BioPharm PLC is proud to announce it has entered into a collaboration agreement with Queen Mary University of London to research the therapeutic potential of gamma-delta T cells for the treatment of mucosal infections.

Schrödinger today announced that management will participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference.

Breathe BioMedical has announced Bill Dawes as their new Chief Executive Officer, effective August 14, 2023.

Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today entered into an amendment to the company’s senior secured credit agreement with BMO as agent and lender.

NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage

BioGenCell, a leader in personalized cell therapy solutions and Westchester Medical Center, the academic affiliate of Touro University/New York Medical College have announced the launch of BioGenCell’s fourth Phase II clinical trial site in the United States.

Phanes Therapeutics, Inc. announced that it has formed a Clinical Advisory Board to enhance the development of its three clinical stage programs: PT199 for solid tumors, PT886 for gastric, gastroesophageal junction and pancreatic adenocarcinomas, and PT217 for small cell lung cancer and other neuroendocrine cancers.

Arcutis Biotherapeutics, Inc., an early-stage commercial company focused on developing meaningful innovations in immuno-dermatology, announced that Arcutis management will participate in an upcoming investor conference.